Previous 10 | Next 10 |
2023-09-06 08:12:04 ET Summary Protalix BioTherapeutics reported Q2 2023 revenues of $35.08 million, a 300.72% YoY increase, beating Wall Street estimates. The US FDA approved PLX's Elfabrio for the treatment of Fabry disease in adults, expanding its commercialization target. ...
2023-09-02 09:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-31 16:35:18 ET Insulin makers Novo Nordisk ( NVO ), Eli Lilly ( NYSE: LLY ) and Sanofi ( NASDAQ: SNY ) have reportedly been asked by two US senators to furnish details by Sept. 15 on their programs for providing low-cost insulin to diabetic patients. Sen. Mag...
2023-08-31 11:17:22 ET Summary Novo Nordisk is a high-quality pharmaceutical company with a unique ownership structure, controlled by a charitable foundation. The company specializes in diabetes and obesity treatments, with a focus on insulin and GLP-1 analogues. Despite a tem...
2023-08-24 09:44:18 ET The Biden administration is expected to announce the first 10 drugs that will be subject to Medicare price negotiations on Tuesday before the markets open, Politico reported, citing people familiar with the plans. The move, introduced as part of last year ...
2023-08-22 08:14:05 ET Summary Review of Apogee Therapeutics' safety and pharmacokinetic data from phase 1 study using APG777 in healthy volunteers expected in mid-2024. Pending positive phase 1 safety and pharmacokinetic data using APG777, the initiation of a 16-week phase 2 stud...
2023-08-19 14:00:56 ET More on Regeneron Pharmaceuticals Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade) Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider Opening Regeneron Pharmaceuticals: Overdependence On Eylea Brought T...
2023-08-18 15:21:26 ET Summary Blue Shield of California has chosen a coalition of providers, including Amazon and Mark Cuban's company, over CVS for its pharmacy benefits manager services. The move is expected to have a minimal impact on CVS's earnings per share in 2025, but coul...
2023-08-18 10:00:00 ET There's a "simple" two-step process to increase one's wealth by investing in the stock market. The first is to buy shares of quality companies. The second is to wait patiently while your money grows. Of course, this process isn't quite as easy as all that. Being patie...
2023-08-15 16:20:35 ET More on Reata Pharmaceuticals Biogen's Bold $7.3B Acquisition Of Reata: Analyzing The Impact On Investors Reata: FDA Approval Of SKYCLARYS Isn't Only Driver Moving Forward Reata Pharmaceuticals: 'Buy' Following Skyclarys Delay And Bardoxolone D...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...